A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
- DRUG: Revefenacin
- DRUG: Placebo
- DRUG: Formoterol
Sponsor
Mylan Inc.
Collaborators